Skip to main content

Day: February 24, 2025

4/2025・Trifork Group AG – Change to the Board of Directors

Company announcement no. 4 / 2025 Schindellegi, Switzerland – 24 February 2025 Change to the Board of Directors Casey Rosenthal, Member of the Board of Directors of Trifork Group AG since 2019, is joining Trifork’s US organization in an operational role and has therefore left the Board of Directors with immediate effect. Casey Rosenthal will be a member of the management team of Trifork US, leading growth in the Platform and Data Engineering space. Pairing his extensive experience in managing large-scale platforms with Trifork’s expertise in building scalable, resilient solutions, Casey Rosenthal will be key in executing Trifork’s ambition to continue the strong growth witnessed in North America in the past years. Before joining Trifork US, Casey Rosenthal was a software entrepreneur and an engineering manager in the Traffic Engineering...

Continue reading

Sunlands Integrates DeepSeek AI Model, Ushering in a New Era for Adult Education

BEIJING, Feb. 24, 2025 (GLOBE NEWSWIRE) — Sunlands Technology Group (NYSE: STG) (“Sunlands” or the “Company”), a leader in China’s adult online education market and China’s adult personal interest learning market, today announced the full integration of DeepSeek, an advanced artificial intelligence (AI) model, into its operations. This marks a new phase in the company’s technological transformation in the adult education sector. By leveraging DeepSeek’s powerful reasoning capabilities and efficient learning mechanisms, Sunlands aims to drive innovation, empower core business functions, and optimize processes in key areas such as teaching and research, customer acquisition, and operational management, ultimately strengthening its leadership position in the industry. Since its inception, Sunlands has been at the forefront of...

Continue reading

Share buyback programme – week 8

Nasdaq CopenhagenLondon Stock ExchangeEuronext DublinDanish Financial Supervisory AuthorityOther stakeholders Date        24 February 2025 Share buyback programme – week 8 The share buyback programme runs in the period 28 January 2025 up to and including 28 May 2025 provided that the forthcoming annual general meeting, to be held on 5 March 2025, gives the board a new authority to permit the bank to acquire its own shares. During the period the bank will thus buy back its own shares for a total of up to DKK 500 million under the programme, but to a maximum of 800,000 shares. The programme is implemented in compliance with EU Commission Regulation No. 596/2014 of 16 April 2014 and EU Commission Delegated Regulation No. 2016/1052 of 8 March 2016, which together constitute the “Safe Harbour” regulation. The following transactions have been...

Continue reading

ProductLife Group Acquires Herax Life Science, Strengthening its Capabilities in R&D Business and IT Consulting

PARIS, Feb. 24, 2025 (GLOBE NEWSWIRE) — ProductLife Group (PLG), a global leader in regulatory, scientific, compliance, and digital transformation consulting for the life sciences industry, is pleased to announce the acquisition of HERAX Life Science, a leading Danish business and technology consultancy providing tailored services and solutions for the life sciences industry. Founded in Copenhagen in 2009, HERAX Life Science has established itself as a highly specialized business and IT consultancy, supporting life sciences companies in digitizing R&D activities, selecting and delivering technology solutions, and optimizing business processes within clinical development. Supported by a team of industry experts, HERAX Life Science leverages methodology, deep process understanding and technology to help clients enhance their...

Continue reading

Societe Generale: Appointment within the Societe Generale Group

APPOINTMENT WITHIN THE SOCIETE GENERALE GROUP Press release Paris, 24 February 2025 Societe Generale announces the appointment of Lubomira Rochet as Executive Vice President in charge of Retail Banking activities in France, Private Banking and Insurance, as well as the Group’s Chief Operating Office (technology, procurement and real estate). She will join the Bank in April 2025. Lubomira will also become a member of the Group Executive Committee. Lubomira Rochet’s mission will be to assist Slawomir Krupa, Chief Executive Officer of Societe Generale, in overseeing Retail Banking activities in France (both SG retail network and BoursoBank), Private Banking and Insurance, as well as the activities of the Group’s Chief Operating Office (including technology, procurement and real estate). Lubomira Rochet is an accomplished...

Continue reading

Sustainably Connected: KPN presents Annual Report 2024

Today, KPN publishes its Integrated Annual Report 2024: Sustainably Connected. KPN achieved its 2024 targets and continued to make good progress towards its mid-term strategic and financial ambitions. In addition to a growth of more than 3% in operating profit, KPN was able to make significant progress in the sustainable digitization of the Netherlands achieving a record number of fiber homes connected. For the first time, the Integrated Annual Report 2024 has been prepared in line with the CSRD guidelines. Annual General Meeting of ShareholdersOn 16 April 2025, KPN will hold its Annual General Meeting of Shareholders, at which the Integrated Annual Report 2024 amongst other items will be discussed. The agenda will be published shortly. The Integrated Annual Report 2024 is available online on the interactive website annualreport2024.kpn. Formal...

Continue reading

Cellectis Presents ‘Smart CAR T’ Strategy to Enhance Efficacy Against Solid Tumors at AACR-IO 2025

NEW YORK, Feb. 24, 2025 (GLOBE NEWSWIRE) — Cellectis (the “Company”) (Euronext Growth: ALCLS – NASDAQ: CLLS), a clinical-stage biotechnology company using its pioneering gene-editing platform to develop life-saving cell and gene therapies, showcases an innovative strategy for T cell engineering that leverages the pro-inflammatory properties of interleukin 2 (IL-2) with the objective to enhance CAR T cell efficacy against solid tumors, at the American Association for Cancer Research – Immuno-oncology (AACR-IO), taking place on February 23-26, 2025 in Los Angeles, CA. The data are presented in a poster: CAR induced expression of synthetically engineered FAP-IL2v immunocytokine boosts persistent anti-tumor activity of TALEN-edited allogeneic CAR T-cells without associated IL-2 toxicity Presenter: Shipra Das, Ph.D., Associate...

Continue reading

OSE Immunotherapeutics Reports Full Phase 2 Induction Results for Anti-IL-7R mAb Lusvertikimab in Ulcerative Colitis at the 20th Congress of ECCO

OSE Immunotherapeutics Reports Full Phase 2 Induction Results for Anti-IL-7R mAb Lusvertikimab in Ulcerative Colitis at the 20th Congress of ECCOLusvertikimab achieved statistical significance on the primary and secondary endpoints in moderate to severe active ulcerative colitis (UC) patients during the 10-week induction period of treatment in the randomized, double-blind CoTikiS Phase 2 study. These results were presented in the Top 10 congress highlights oral plenary session at ECCO 2025. Lusvertikimab demonstrated high rates of clinical and endoscopic remission after 10 weeks of treatment, along with clinically meaningful histological improvement and Histo-Endoscopic Mucosal Improvement (HEMI) rates. Treatment with Lusvertikimab significantly reduced fecal calprotectin (FCP) after 10 weeks of treatment, an objective biomarker of mucosal...

Continue reading

Exosens strengthens its position as a key supplier to Senop for night vision image intensifier tubes highlighting increasing demand for night vision goggles

EXOSENS STRENGTHENS ITS POSITION AS A KEY SUPPLIER TO SENOP FOR NIGHT VISION IMAGE INTENSIFIER TUBES HIGHLIGHTING INCREASING DEMAND FOR NIGHT VISION GOGGLES PRESS RELEASEMÉRIGNAC, FRANCE – FEBRUARY, 24th 2025Exosens announces that Senop, a Finnish provider of high-tech optronic solutions including night vision goggles, has placed several significant orders for its Photonis white phosphor 4G intensifier tubes, to be delivered over 2025. Third contracts signed with Senop since 2021 confirming Exosens position as the strategic supplier of image intensifier tubes for Baltic and Nordic countries underscoring the potential for material new sales in this area. Rising demand for Night Vision goggles driven by increased military budgets and demonstrated criticality of night vision. Exosens continue to fully benefit from this increasing demand...

Continue reading

Globe Telecom, Nokia collaborate on network APIs to provide banks with enhanced security #MWC25

Press releaseGlobe Telecom, Nokia collaborate on network APIs to provide banks with enhanced security #MWC25Globe tests Nokia’s Network Exposure Platform (NEP) to enhance security in financial services.24 February 2025Espoo, Finland – Globe Telecom, one of the largest telecommunications operators in the Philippines with over 60 million subscribers, today announced that it is collaborating with Nokia to provide banks and other enterprises with enhanced security through the utilization of network Application Programming Interfaces (APIs). Globe Telecom, which already uses a host of other Nokia solutions including 5G RAN, is testing Nokia’s Network Exposure Platform in expanding and simplifying the number of APIs available to the operator and its enterprise partners to enable the creation of security-focused applications. APIs provide...

Continue reading

Disclaimer & Cookie Notice

Welcome to GOLDEA services for Professionals

Before you continue, please confirm the following:

Professional advisers only

I am a professional adviser and would like to visit the GOLDEA CAPITAL for Professionals website.

Important Notice for Investors:

The services and products offered by Goldalea Capital Ltd. are intended exclusively for professional market participants as defined by applicable laws and regulations. This typically includes institutional investors, qualified investors, and high-net-worth individuals who have sufficient knowledge, experience, resources, and independence to assess the risks of trading on their own.

No Investment Advice:

The information, analyses, and market data provided are for general information purposes only and do not constitute individual investment advice. They should not be construed as a basis for investment decisions and do not take into account the specific investment objectives, financial situation, or individual needs of any recipient.

High Risks:

Trading in financial instruments is associated with significant risks and may result in the complete loss of the invested capital. Goldalea Capital Ltd. accepts no liability for losses incurred as a result of the use of the information provided or the execution of transactions.

Sole Responsibility:

The decision to invest or not to invest is solely the responsibility of the investor. Investors should obtain comprehensive information about the risks involved before making any investment decision and, if necessary, seek independent advice.

No Guarantees:

Goldalea Capital Ltd. makes no warranties or representations as to the accuracy, completeness, or timeliness of the information provided. Markets are subject to constant change, and past performance is not a reliable indicator of future results.

Regional Restrictions:

The services offered by Goldalea Capital Ltd. may not be available to all persons or in all countries. It is the responsibility of the investor to ensure that they are authorized to use the services offered.

Please note: This disclaimer is for general information purposes only and does not replace individual legal or tax advice.